Literature DB >> 25883074

Stereoselective reaction of 2-carboxythioesters-1,3-dithiane with nitroalkenes: an organocatalytic strategy for the asymmetric addition of a glyoxylate anion equivalent.

Elisabetta Massolo1, Maurizio Benaglia, Andrea Genoni, Rita Annunziata, Giuseppe Celentano, Nicoletta Gaggero.   

Abstract

An efficient organocatalytic methodology has been developed to perform the stereoselective addition of 2-carboxythioesters-1,3-dithiane to nitroalkenes. Under mild reaction conditions γ-nitro-β-aryl-α-keto esters with up to 92% ee were obtained, realizing a formal catalytic stereoselective conjugate addition of the glyoxylate anion synthon. The reaction products are versatile starting materials for further synthetic transformations; for example, the simultaneous reduction of the nitro group and removal of the dithiane ring was accomplished, allowing the preparation of a GABAB receptor agonist baclofen.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25883074     DOI: 10.1039/c5ob00492f

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  3 in total

Review 1.  Asymmetric Michael Addition in Synthesis of β-Substituted GABA Derivatives.

Authors:  Jianlin Han; Jorge Escorihuela; Santos Fustero; Aitor Landa; Vadim A Soloshonok; Alexander Sorochinsky
Journal:  Molecules       Date:  2022-06-13       Impact factor: 4.927

2.  Phosphazene-catalyzed desymmetrization of cyclohexadienones by dithiane addition.

Authors:  Matthew A Horwitz; Elisabetta Massolo; Jeffrey S Johnson
Journal:  Beilstein J Org Chem       Date:  2017-04-24       Impact factor: 2.883

3.  Photoredox radical conjugate addition of dithiane-2-carboxylate promoted by an iridium(iii) phenyl-tetrazole complex: a formal radical methylation of Michael acceptors.

Authors:  Andrea Gualandi; Elia Matteucci; Filippo Monti; Andrea Baschieri; Nicola Armaroli; Letizia Sambri; Pier Giorgio Cozzi
Journal:  Chem Sci       Date:  2016-11-03       Impact factor: 9.825

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.